AC Immune S.A. (ACIU) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of AC Immune S.A. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACIU vs QTTB

growth of $100 · dividends reinvested · last 9y
ACIU -74.7% (-14.2%/yr)QTTB -97.5% (-33.7%/yr)ACIU compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002020202220242026$25$2
ACIU QTTB

ACIU vs QTTB: by the numbers

  • •ACIU is the larger company ($260M vs $244M market cap).
  • •QTTB is profitable (62.87% net margin) while ACIU runs a net loss (-249.94%).
  • •QTTB grew revenue faster over the past five years (10.22% vs -23.70% CAGR).

Metrics side by side

Valuation

MetricACIUQTTB
P/E ratioN/A2.94
P/S ratio11.964.54
P/B ratio5.962.30
EV / EBITDAN/A6.53

Profitability

MetricACIUQTTB
Gross margin100.00%99.84%
Operating margin-1927.32%31.45%
Net margin-249.94%62.87%
ROE-124.67%31.90%
ROIC-89.43%19.43%

Growth (annualized)

MetricACIUQTTB
Revenue CAGR (5Y)-23.70%10.22%
Total return CAGR (5Y)-16.03%-41.51%

Frequently asked

Which has grown faster, ACIU or QTTB?
Over the past five years, QTTB grew revenue faster — ACIU at a -23.70% CAGR versus QTTB at 10.22%.
Is ACIU or QTTB more profitable?
QTTB runs the higher net margin — ACIU at -249.94% versus QTTB at 62.87%.
How have ACIU and QTTB total returns compared?
Over the past 5 years, ACIU delivered -16.03% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.